10-Q: Rest EZ Reports Zero Revenue, Going Concern Doubts Persist

Rest EZ, Inc. reported no revenue and a net loss of $0 for the quarter ended June 30, 2025, with management expressing substantial doubt about its ability to continue as a going concern.

Summary

• Reported zero revenue for the three months ended June 30, 2025, consistent with the prior year period.
• Experienced a net loss of $0 for the quarter ended June 30, 2025, an improvement from a $33 net loss in the same period last year.
• Maintained total assets and stockholders' equity at $300 as of June 30, 2025.
• Accumulated deficit stands at $286,101 as of June 30, 2025.
• Management identified substantial doubt about the company's ability to continue as a going concern due to lack of capital and inability to generate profits.
• Disclosure controls and procedures were deemed ineffective, and material weaknesses in internal control over financial reporting were identified.
• The company operates with a single product, Rest EZ Sleep Aid Supplement, manufactured by an unaffiliated provider.

Sentiment

Score: 1

Explanation: The company faces severe financial distress with zero revenue, minimal assets, an accumulated deficit, and significant going concern doubts. The identified material weaknesses in internal controls and lack of proprietary products further exacerbate its precarious position, indicating a very high risk profile.

Positives

• Net loss improved to $0 for the quarter ended June 30, 2025, compared to a $33 net loss in the prior year period.
• The company is in "full production and distribution" of its single product.
• The corporate office is provided free of charge by the CEO, reducing overhead.

Negatives

• Zero revenue generated for the three months ended June 30, 2025, and 2024.
• An accumulated deficit of $286,101 as of June 30, 2025.
• Substantial doubt exists about the company's ability to continue as a going concern without additional capital and profit generation.
• Disclosure controls and procedures were ineffective as of June 30, 2025.
• Material weaknesses in internal control over financial reporting include insufficient accounting resources, lack of segregation of duties, absence of an independent board or audit committee, and lack of written control documentation.
• The company has no proprietary technology or intellectual property related to its product.
• High competition from large, established companies in the sleep aid market.
• Sole executive officer and director, Dylan Carson, presents a key person risk.

Risks

• Inability to raise necessary capital to sustain operations and implement the business plan.
• Failure to generate sufficient cash to pay lenders and other creditors.
• Difficulty in employing and retaining qualified management and employees.
• High dependence on the efforts and abilities of the current sole executive officer and director, Dylan Carson.
• Changes in government regulations applicable to the business.
• Changes in demand for sleep aid supplements.
• Intense competition from large, established companies with substantial capabilities and long earnings records.
• Lack of diversification of the business plan, relying on a single product.
• General volatility of the capital markets and challenges in establishing a market for the company's shares.
• Disruptions from economic and financial conditions, health pandemics, and environmental weather conditions.
• No assurance that a suitable replacement could be found for the sole executive officer and director upon their departure.
• The company may not be able to remain in business without additional capital.

Future Outlook

The company plans to build its reputation and expand to additional wholesalers, retail chain stores, and public sales over the next twelve months. However, its ability to continue as a going concern is dependent on identifying future investment opportunities, obtaining necessary financing, and generating profits.

Management Comments

• The Company has begun to recognize revenue, but without additional capital, the Company may not be able to remain in business.
• Achievement of Rest EZ, Inc.'s business objective is basically dependent upon the judgment, skill and knowledge of the Company's management.
• We believe our product is superior to that of the competition due to the product being in a soft gel form, avoiding substantial product break down before digestion as happens with many competitors products.
• Mr. Sosa indicates he has enough room to store 100,000 bottles of Rest EZ product, so no additional room is needed at this time, or in the near future.
• In the opinion of management, inflation has not had a material effect on the Company's financial condition or results of operations.

Industry Context

Rest EZ, Inc. operates in the highly competitive dietary supplement market, specifically for sleep aids. This market is characterized by the presence of large, established companies with significant resources and long operating histories. The company's lack of proprietary technology and reliance on a single product, coupled with minimal revenue, places it at a significant disadvantage compared to industry leaders. The regulatory environment for dietary supplements, where FDA approval is not required for marketing, allows for easier market entry but also intensifies competition.

Comparison to Industry Standards

• The company's zero revenue and minimal assets ($300) are significantly below industry standards for publicly traded companies, even those in the early stages of growth.
• Established dietary supplement companies like Nature's Bounty, GNC, or even smaller successful brands typically report millions in quarterly revenue and substantial asset bases.
• The identified material weaknesses in internal controls and lack of an independent board are far below corporate governance standards expected of public companies, regardless of size.
• The reliance on a single, non-proprietary product in a competitive market without significant capital or intellectual property contrasts sharply with successful industry players who often have diverse product portfolios, strong branding, and patented formulations.

Management Changes

Corporate Governance

Related Party Transactions

• The corporate office at 8928 South Black Pine Street, West Jordan, Utah 84088, is provided to the company free of charge by the current CEO, Dylan Carson.
• A previous $13,500 loan from former President Brandon Sosa was forgiven and satisfied through shares of stock he retained; Mr. Sosa is no longer considered a related party.

Stakeholder Impact

• Shareholders: Face significant risk of capital loss due to the company's going concern doubts, zero revenue, and minimal assets. The ineffectiveness of internal controls also poses a risk to the accuracy and reliability of financial information.
• Employees: The company's precarious financial state and dependence on a single executive suggest high job insecurity and limited growth opportunities.
• Customers: Potential risk of product availability or company longevity if the going concern issues are not resolved.
• Suppliers: Risk of non-payment if the company fails to secure additional capital and generate revenue.
• Creditors: High risk of default given the company's minimal cash, zero revenue, and explicit going concern warning.

Next Steps

• Build out the company's reputation.
• Expand to additional wholesalers and retail chain stores.
• Expand sales to the public.
• Identify future investment opportunities.
• Obtain necessary debt and/or equity financing.
• Generate profits from future operations.

Key Dates

Recommendation

The company exhibits fundamental weaknesses that make it an extremely high-risk investment. Zero revenue, minimal assets, an accumulated deficit, and explicit 'going concern' doubts indicate severe financial distress. The identified material weaknesses in internal controls and corporate governance, coupled with a lack of proprietary products in a highly competitive market, suggest a very low probability of long-term viability or shareholder value creation. Without significant, immediate, and successful capital infusion and a drastic improvement in operations and governance, the company faces a high likelihood of failure.

Keywords

Rest EZ Inc, 10-Q, Quarterly Report, Sleep Aid Supplement, Dietary Supplement, Going Concern, Financial Reporting, SEC Filing, Corporate Governance, Internal Controls, Net Loss, Zero Revenue, Microcap, OTC Markets